Superworth

TuHURA Biosciences EPS HURA

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to Jun 30, 2026
−$0.54
Latest quarter, Q2 FY26
−$0.14
Fiscal year 2025
−$0.63

TuHURA Biosciences' earnings per share was −$0.54 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.14.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$0.63n/a
FY2024n/an/a
FY2024−$1.53−100%
FY2014$9100.00n/a
FY2013−$35700.00n/a
FY2012−$7700.00n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.14n/a−$0.54
Q1 FY26−$0.13n/a−$0.61
Q4 FY25−$0.13n/a−$0.63
Q3 FY25−$0.14n/a−$0.66
Q2 FY25−$0.21n/a−$1.06
Q1 FY25−$0.15n/a−$1.28
Q4 FY24−$0.16n/a−$1.53
Q2 FY24−$0.54n/an/a
Q4 FY24−$0.43n/an/a
Q3 FY24−$0.40n/an/a
Q3 FY17−$3150.00−280%n/a
Q2 FY17−$2275.00−154%n/a

Against its peers

Companies in Drug Manufacturers - General nearest TuHURA Biosciences' size, closest first, today.

CompanyEPS, 12 monthsGrowth
HURATuHURA Biosciences−$0.54
NATRNatures Sunshine Products$1.01+36% a year
LFVNLifevantage$0.40−46% a year
SPROSpero Therapeutics$0.11
ATNMActinium Pharmaceuticals$0.36
ARVNArvinas$0.16
PBYIPuma Biotechnology$0.52−47% a year
IRWDIronwood Pharmaceuticals$0.77
ZVRAZevra Therapeutics$0.93
CRMDCorMedix$2.13+184% a year
COLLCollegium Pharmaceutical$1.24+19% a year
Peer median$0.65

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on TuHURA Biosciences

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.